To assess the efficacy of TrueContour® Insoles versus the current standard of care insoles in recurrence of plantar MTH ulcers in men and women, 18 years of age or older at the time of consent with clinical diagnosis of Diabetes Mellitus type 1 or type 2 who have had at least one recently healed plantar MTH foot ulcer (\>1 week but \<12 weeks since heeling) and have Loss of Protective Sensation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
130
Novel designed insole
Current Medicare approved A5513 insole
Carl T Hayden VA Medical Center
Phoenix, Arizona, United States
Southern Arizona Limb Salvage Alliance
Tucson, Arizona, United States
Center for Clinical Research, Inc
Castro Valley, California, United States
The first occurrence of a plantar ulcer or pre-ulcer in subjects who have had one previously healed plantar ulcer
Time frame: every 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Innovative Medical Technologies
Los Angeles, California, United States
Diabetic Foot and Wound Center
Denver, Colorado, United States
Weil Foot & Ankle Institute
Des Plaines, Illinois, United States
Hines VA Hospital
Hines, Illinois, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Blair Medical Associates, Inc
Altoona, Pennsylvania, United States
Temple University School of Podiatric Medicine
Philadelphia, Pennsylvania, United States
...and 1 more locations